Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

2.91USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
123,679
52-wk High
$5.10
52-wk Low
$2.20

Latest Key Developments (Source: Significant Developments)

Adamis Pharmaceuticals Provides Update On Symjepi's U.S. Launch
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS PROVIDES UPDATE ON THE U.S. LAUNCH OF SYMJEPI.ADAMIS PHARMACEUTICALS - PROVIDED BUSINESS UPDATE ANNOUNCING U.S. LAUNCH OF FDA-APPROVED SYMJEPI 0.3MG INJECTION IS PLANNED FOR EARLY Q1 2019..ADAMIS PHARMACEUTICALS - MANUFACTURE OF COMMERCIAL BATCHES COMPLETED, ADAMIS WILL BEGIN SHIPPING TO SANDOZ DISTRIBUTION CENTERS DURING DEC.  Full Article

Adamis Pharmaceuticals Reports Q3 Revenue Of $3.8 Million
Friday, 9 Nov 2018 

Nov 9 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE.Q3 REVENUE $3.8 MILLION.Q3 REVENUE VIEW $5.2 MILLION -- THOMSON REUTERS I/B/E/S.AT SEPTEMBER 30, 2018, COMPANY HAD CASH AND CASH EQUIVALENTS OF $32.0 MILLION.EXPECTS THAT RESEARCH AND DEVELOPMENT SPENDING IN Q4 OF 2018 WILL SEE AN INCREASE.  Full Article

Adamis Pharmaceuticals Receives FDA Approval For Its Lower Dose Symjepi Product
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS RECEIVES FDA APPROVAL FOR ITS LOWER DOSE SYMJEPI PRODUCT.  Full Article

Adamis Pharmaceuticals Says Working With Sandoz To Prepare Symjepi Launch
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS PROVIDES BUSINESS UPDATE.ADAMIS PHARMACEUTICALS - WORKING CLOSELY WITH SANDOZ TO PREPARE A SUCCESSFUL LAUNCH FOR SYMJEPI.ADAMIS PHARMACEUTICALS - FDA PROVIDED PDUFA DATE OF SEPT 27, 2018 FOR LOW DOSE SYMJEPI PRODUCT CANDIDATE.ADAMIS PHARMACEUTICALS - LOW DOSE SYMJEPI PRODUCT CANDIDATE IS STILL UNDER REVIEW WITH U.S. FDA.  Full Article

Adamis Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Adamis Pharmaceuticals Files For Mixed Shelf Of Up To $150 Mln
Monday, 9 Jul 2018 

July 10 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS CORP FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING.  Full Article

Adamis Pharmaceuticals Says Unless Earlier Terminated, Deal With Sandoz Will Expire 10 Yrs From Launch Of Product
Monday, 2 Jul 2018 

July 2 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS - DEAL WITH SANDOZ FOR SYMJEPI PROVIDES SANDOZ WILL PAY TO CO 50% OF NET PROFIT FROM NET SALES OF PRODUCT.ADAMIS PHARMACEUTICALS - UNLESS EARLIER TERMINATED, DEAL WITH SANDOZ WILL EXPIRE 10 YRS FROM LAUNCH OF PRODUCT, WITH ANNUAL RENEWAL TERMS THEREAFTER.  Full Article

Adamis Pharmaceuticals Announces Submission Of Investigational New Drug (Ind) Application To The FDA
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION TO THE FDA FOR NEW PRODUCT CANDIDATE FOR THE TREATMENT OF OPIOID OVERDOSE.  Full Article

Adamis Pharma Submits Prior Approval Supplement To FDA For The Pediatric Version Of Symjepi
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Adamis Pharmaceuticals Corp ::ADAMIS PHARMACEUTICALS SUBMITS PRIOR APPROVAL SUPPLEMENT TO FDA FOR THE PEDIATRIC VERSION OF SYMJEPI.ADAMIS PHARMACEUTICALS CORP - SUBMISSION OF A PRIOR APPROVAL SUPPLEMENT TO U.S. FOOD AND DRUG ADMINISTRATION FOR PEDIATRIC VERSION (0.15MG) OF SYMJEPI.  Full Article

Swiss stocks - Factors to watch on Dec. 7

ZURICH/BERLIN, Dec 7 The Swiss blue-chip SMI was seen opening 1.2 percent higher at 8,765 points on Friday, according to premarket indications by bank Julius Baer .